✦ LIBER ✦

Upfront transplantation for poor-risk aggressive non-hodgkin lymphoma and hodgkin’s disease: Who benefits?

✍ Scribed by Tarun Kewalramani; Craig H. Moskowitz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic options for patients with ho

✍ Koen van Besien; Sonali Smith; Hillard M. Lazarus 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 284 KB

The potential benefits of therapeutic sp

✍ David P. Schreiber; Charlotte Jacobs; Saul A. Rosenberg; Richard S. Cox; Richard 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 665 KB

Infusions of interleukin-1α after autolo

✍ Emmanuel Katsanis; Daniel J. Weisdorf; Zhiyi Xu; Betsy B. Dancisak; Mary L. Hale 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 642 KB

Phase-I–II study of high-dose melphalan

✍ B. Mascret; D. Maraninchi; J. A. Gastaut; D. Baume; G. Sebahoun; C. Lejeune; G. 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 587 KB

Autologous bone marrow transplantation f

✍ J. W. Sweetenham 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Long-term results of autologous stem cel

✍ David Nachbaur; Hildegard T. Greinix; Elisabeth Koller; Otto Krieger; Werner Lin 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 175 KB